Natalizumab: increased vigilance is required in treating patients with multiple sclerosis
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2008-11-01
|
| Series: | Therapeutic Advances in Neurological Disorders |
| Online Access: | https://doi.org/10.1177/1756285608099125 |
| _version_ | 1811327874530017280 |
|---|---|
| author | Michael K. Racke Olaf Stüve |
| author_facet | Michael K. Racke Olaf Stüve |
| author_sort | Michael K. Racke |
| collection | DOAJ |
| first_indexed | 2024-04-13T15:15:36Z |
| format | Article |
| id | doaj.art-646666d5dedd40c4b835ef96d9935608 |
| institution | Directory Open Access Journal |
| issn | 1756-2856 |
| language | English |
| last_indexed | 2024-04-13T15:15:36Z |
| publishDate | 2008-11-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Therapeutic Advances in Neurological Disorders |
| spelling | doaj.art-646666d5dedd40c4b835ef96d99356082022-12-22T02:41:53ZengSAGE PublishingTherapeutic Advances in Neurological Disorders1756-28562008-11-01110.1177/1756285608099125Natalizumab: increased vigilance is required in treating patients with multiple sclerosisMichael K. RackeOlaf Stüvehttps://doi.org/10.1177/1756285608099125 |
| spellingShingle | Michael K. Racke Olaf Stüve Natalizumab: increased vigilance is required in treating patients with multiple sclerosis Therapeutic Advances in Neurological Disorders |
| title | Natalizumab: increased vigilance is required in treating patients with multiple sclerosis |
| title_full | Natalizumab: increased vigilance is required in treating patients with multiple sclerosis |
| title_fullStr | Natalizumab: increased vigilance is required in treating patients with multiple sclerosis |
| title_full_unstemmed | Natalizumab: increased vigilance is required in treating patients with multiple sclerosis |
| title_short | Natalizumab: increased vigilance is required in treating patients with multiple sclerosis |
| title_sort | natalizumab increased vigilance is required in treating patients with multiple sclerosis |
| url | https://doi.org/10.1177/1756285608099125 |
| work_keys_str_mv | AT michaelkracke natalizumabincreasedvigilanceisrequiredintreatingpatientswithmultiplesclerosis AT olafstuve natalizumabincreasedvigilanceisrequiredintreatingpatientswithmultiplesclerosis |